Indian Company Master Data Made Simple
Sun Pharma Advanced Research Company Limited
Sun Pharma Advanced Research Company Limited, formed in 2006, has been in existence for 2. Its CIN is L73100GJ2006PLC047837, with registration number 47837. It falls under the category of company limited by shares. The company has an authorized share capital of ₹42.50 crore. Sun Pharma Advanced Research Company Limited’s paid-up capital stands at ₹32.45 crore.
The company’s main operations are related to research and development. The company’s registration location is Ahmedabad. Sun Pharma Advanced Research Company Limited’s registered office is at Plot No. 5 & 6/1, Savli G.i.d.c. Estate, Savli – Vadodara Highway, Vadodara, Manjusar, Gujarat, India, 391775. It is an active company at present. The entity’s PAN (Permanent Account Number) stands as AAJCS8340R. Sun Pharma Advanced Research Company Limited holds the LEI code 3358001Y3QHHUNROTJ51. The firm’s registered email for correspondence is secretarial@sparcmail.com. The leadership team includes Anil Kumar (CEO), Anup Madanmohan Rathi (CFO), Anil Kumar (CEO) and Anup Madanmohan Rathi (CFO).
Company Overview
- CIN
- Date of Incorporation
- 28/02/2006
- Company Status
- Active
- RoC
- Ahmedabad
- Registration Number
- Balance sheet date
- 31/03/2025
- Company Category
- Company limited by shares
- Company Sub Category
- Non-government company
- Listed in Stock Exchange
- Yes
- Class of Company
- Public Limited Company
- LEI Number
- LEI Status
- Issued
- Authorized Capital
- ₹42,50,00,000.00
- Paid up Capital
- ₹32,45,21,588.00
- Activity
- Research And Development
- secretarial@sparcmail.com
- PAN
GST Numbers
| State | GST Number | Status |
|---|---|---|
| Gujarat | 24AAJCS8340R1ZN | Active |
| Maharashtra | 27AAJCS8340R2ZG | Active |
| 27AAJCS8340R1ZH | Active |
ISIN Numbers
| ISIN | Security | Interest Rate | Maturity Date | FISN | CFI |
|---|---|---|---|---|---|
| IN9232I01012 | SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED EQ PP Re. 0.60/- | - | 12/10/2026 | SUN PHARMA ADRE/SH VTG PP | ESVUPN |
| INE232I01014 | SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED EQ | - | 12/10/2026 | SUN PHARMA ADRE/SH VTG | ESVUFN |
| IN8232I01013 | SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED EQ LISTING/TRADING APPROVAL AWAITED | - | 12/10/2026 | SUN PHARMA ADRE/SH VTG | ESVUFN |
Balance Sheet
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2018 | 31/03/2014 |
|---|---|---|---|---|---|---|---|
| Net PPE | ₹8,568.03L | ₹9,925.54L | ₹10,903.64L | ₹10,902.78L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Debt | ₹55,498.47L | ₹25,622.14L | ₹4,167.05L | ₹0.00L | ₹7,377.58L | ₹0.00L | ₹0.00L |
| Gross PPE | ₹14,318.39L | ₹15,748.06L | ₹15,763.96L | ₹14,868.56L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Debt | ₹55,780.01L | ₹26,513.47L | ₹5,766.09L | ₹1,567.53L | ₹0.00L | ₹0.00L | ₹0.00L |
| Common Stock | ₹3,245.30L | ₹3,245.30L | ₹3,245.30L | ₹3,245.30L | ₹0.00L | ₹0.00L | ₹0.00L |
| Current Debt | ₹55,614.00L | ₹15,818.53L | ₹4,700.00L | ₹5.10L | ₹0.00L | ₹0.00L | ₹0.00L |
| Share Issued | ₹3,245.22L | ₹3,245.22L | ₹3,245.22L | ₹3,245.22L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Assets | ₹2,17,087.62L | ₹33,553.35L | ₹51,504.22L | ₹83,012.61L | ₹0.00L | ₹0.00L | ₹0.00L |
| Capital Stock | ₹3,245.30L | ₹3,245.30L | ₹3,245.30L | ₹3,245.30L | ₹0.00L | ₹0.00L | ₹0.00L |
| Long Term Debt | ₹0.00L | ₹10,000.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Current Assets | ₹1,86,242.70L | ₹2,619.69L | ₹26,938.56L | ₹45,496.27L | ₹0.00L | ₹0.00L | ₹0.00L |
| Prepaid Assets | ₹588.60L | ₹565.47L | ₹5,370.90L | ₹1,289.32L | ₹0.00L | ₹0.00L | ₹0.00L |
| Working Capital | ₹1,10,832.09L | -₹34,804.34L | ₹432.78L | ₹27,601.70L | ₹0.00L | ₹0.00L | ₹0.00L |
| Invested Capital | ₹1,89,496.72L | ₹4,123.73L | ₹17,275.54L | ₹51,282.61L | ₹0.00L | ₹0.00L | ₹0.00L |
| Other Properties | ₹696.86L | ₹1,780.22L | ₹1,767.20L | ₹1,787.78L | ₹0.00L | ₹0.00L | ₹0.00L |
| Retained Earnings | -₹76,632.75L | -₹2,32,160.48L | -₹1,97,883.99L | -₹1,59,181.34L | ₹0.00L | ₹0.00L | ₹0.00L |
| Common Stock Equity | ₹1,33,882.72L | -₹21,694.80L | ₹12,575.54L | ₹51,277.51L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Tangible Assets | ₹1,26,747.79L | -₹27,060.06L | ₹8,304.35L | ₹48,730.69L | ₹0.00L | ₹0.00L | ₹0.00L |
| Tangible Book Value | ₹1,26,747.79L | -₹27,060.06L | ₹8,304.35L | ₹48,730.69L | ₹0.00L | ₹0.00L | ₹0.00L |
| Current Liabilities | ₹75,410.61L | ₹37,424.03L | ₹26,505.78L | ₹17,894.57L | ₹0.00L | ₹0.00L | ₹0.00L |
| Long Term Provisions | ₹1,234.00L | ₹768.00L | ₹605.00L | ₹814.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Stockholders Equity | ₹1,33,882.72L | -₹21,694.80L | ₹12,575.54L | ₹51,277.51L | ₹0.00L | ₹0.00L | ₹0.00L |
| Other Equity Interest | ₹1,30,637.00L | -₹24,940.00L | ₹9,330.24L | ₹48,032.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Capitalization | ₹1,33,882.72L | -₹11,694.80L | ₹12,575.54L | ₹51,277.51L | ₹0.00L | ₹0.00L | ₹0.00L |
| Ordinary Shares Number | ₹3,245.22L | ₹3,245.22L | ₹3,245.22L | ₹3,245.22L | ₹0.00L | ₹0.00L | ₹0.00L |
| Other Intangible Assets | ₹7,134.93L | ₹5,365.26L | ₹4,271.19L | ₹2,546.82L | ₹0.00L | ₹0.00L | ₹0.00L |
| Other Non Current Assets | ₹9,109.00L | ₹7,185.00L | ₹80.00L | ₹241.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Non Current Assets | ₹30,844.92L | ₹30,933.66L | ₹24,565.66L | ₹37,516.34L | ₹0.00L | ₹0.00L | ₹0.00L |
| Cash And Cash Equivalents | ₹115.53L | ₹196.39L | ₹532.95L | ₹58.36L | ₹0.00L | ₹0.00L | ₹0.00L |
| Construction In Progress | ₹49.72L | ₹56.07L | ₹168.90L | ₹362.08L | ₹0.00L | ₹0.00L | ₹0.00L |
| Accumulated Depreciation | -₹5,750.36L | -₹5,822.52L | -₹4,860.32L | -₹3,965.78L | ₹0.00L | ₹0.00L | ₹0.00L |
| Additional Paid In Capital | ₹2,03,815.89L | ₹2,03,815.89L | ₹2,03,815.89L | ₹2,03,815.89L | ₹0.00L | ₹0.00L | ₹0.00L |
| Other Short Term Investments | ₹13.19L | ₹236.00L | ₹15,180.13L | ₹40,188.93L | ₹0.00L | ₹0.00L | ₹0.00L |
| Other Non Current Liabilities | ₹6,260.00L | ₹6,260.00L | ₹10,349.43L | ₹11,765.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Machinery Furniture Equipment | ₹9,664.36L | ₹10,004.32L | ₹9,938.84L | ₹8,879.04L | ₹0.00L | ₹0.00L | ₹0.00L |
| Goodwill And Other Intangible Assets | ₹7,134.93L | ₹5,365.26L | ₹4,271.19L | ₹2,546.82L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Equity Gross Minority Interest | ₹1,33,882.72L | -₹21,694.80L | ₹12,575.54L | ₹51,277.51L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Liabilities Net Minority Interest | ₹83,204.90L | ₹55,248.15L | ₹38,928.68L | ₹31,735.10L | ₹0.00L | ₹0.00L | ₹0.00L |
| Current Debt And Capital Lease Obligation | ₹55,614.00L | ₹15,818.53L | ₹4,700.00L | ₹305.53L | ₹0.00L | ₹0.00L | ₹0.00L |
| Long Term Debt And Capital Lease Obligation | ₹166.01L | ₹10,694.94L | ₹1,066.09L | ₹1,262.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Cash Cash Equivalents And Short Term Investments | ₹128.72L | ₹196.39L | ₹15,713.08L | ₹40,247.29L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Non Current Liabilities Net Minority Interest | ₹7,794.29L | ₹17,824.12L | ₹12,422.90L | ₹13,840.53L | ₹0.00L | ₹0.00L | ₹0.00L |
Cash Flow
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2018 | 31/03/2014 |
|---|---|---|---|---|---|---|---|
| Free Cash Flow | -₹26,260.75L | -₹37,063.27L | -₹45,569.62L | -₹8,450.46L | ₹0.00L | ₹0.00L | ₹0.00L |
| Changes In Cash | -₹88.73L | -₹337.75L | ₹474.39L | -₹64.06L | ₹0.00L | ₹0.00L | ₹0.00L |
| End Cash Position | ₹115.53L | ₹196.39L | ₹532.95L | ₹58.36L | ₹0.00L | ₹0.00L | ₹0.00L |
| Financing Cash Flow | ₹26,138.59L | ₹19,925.56L | ₹4,240.51L | ₹61,675.53L | ₹0.00L | ₹0.00L | ₹0.00L |
| Investing Cash Flow | -₹2,349.64L | ₹15,766.00L | ₹39,152.71L | -₹54,827.80L | ₹0.00L | ₹0.00L | ₹0.00L |
| Operating Cash Flow | -₹23,877.68L | -₹36,029.31L | -₹42,918.83L | -₹6,911.79L | ₹0.00L | ₹0.00L | ₹0.00L |
| Capital Expenditure | -₹2,383.07L | -₹1,033.96L | -₹2,650.79L | -₹1,538.67L | ₹0.00L | ₹0.00L | ₹0.00L |
| Beginning Cash Position | ₹196.39L | ₹532.95L | ₹58.36L | ₹122.42L | ₹0.00L | ₹0.00L | ₹0.00L |
Income Statement
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2018 | 31/03/2014 |
|---|---|---|---|---|---|---|
| EBIT | ₹1,58,459.79L | -₹33,424.22L | -₹38,563.73L | -₹21,494.88L | ₹0.00L | ₹0.00L |
| EBITDA | ₹1,59,480.58L | -₹32,184.74L | -₹37,312.68L | -₹20,317.80L | ₹0.00L | ₹0.00L |
| Basic EPS | ₹0.00L | -₹0.00L | -₹0.00L | -₹0.00L | ₹0.00L | ₹0.00L |
| Net Income | ₹1,55,320.43L | -₹34,250.94L | -₹38,721.39L | -₹22,258.35L | ₹0.00L | ₹0.00L |
| Diluted EPS | ₹0.00L | -₹0.00L | -₹0.00L | -₹0.00L | ₹0.00L | ₹0.00L |
| Gross Profit | -₹1,223.96L | -₹3,819.36L | -₹6,024.06L | ₹6,204.36L | ₹0.00L | ₹0.00L |
| Pretax Income | ₹1,55,300.99L | -₹34,278.12L | -₹38,683.19L | -₹22,258.35L | ₹0.00L | ₹0.00L |
| Tax Provision | -₹19.44L | -₹27.18L | ₹38.20L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Revenue | ₹3,914.83L | ₹7,176.60L | ₹7,554.53L | ₹23,878.01L | ₹8,320.00L | ₹17,703.00L |
| Cost Of Revenue | ₹5,138.79L | ₹10,995.96L | ₹13,578.59L | ₹17,673.65L | ₹0.00L | ₹0.00L |
| Total Expenses | -₹1,55,978.11L | ₹40,583.00L | ₹48,704.94L | ₹46,242.44L | ₹0.00L | ₹0.00L |
| Interest Income | ₹1,028.73L | ₹68.21L | ₹2,547.59L | ₹759.54L | ₹0.00L | ₹0.00L |
| Interest Expense | ₹3,158.80L | ₹853.90L | ₹119.46L | ₹763.47L | ₹0.00L | ₹0.00L |
| Operating Income | ₹1,59,892.94L | -₹33,406.40L | -₹41,150.41L | -₹22,364.43L | ₹0.00L | ₹0.00L |
| Tax Rate For Calcs | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Normalized EBITDA | ₹1,60,693.16L | -₹32,293.50L | -₹37,688.92L | -₹20,633.03L | ₹0.00L | ₹0.00L |
| Normalized Income | ₹1,56,047.98L | -₹34,359.61L | -₹38,984.76L | -₹22,573.58L | ₹0.00L | ₹0.00L |
| Operating Expense | -₹1,61,116.90L | ₹29,587.04L | ₹35,126.35L | ₹28,568.79L | ₹0.00L | ₹0.00L |
| Operating Revenue | ₹3,914.83L | ₹7,176.60L | ₹7,554.53L | ₹23,878.01L | ₹0.00L | ₹0.00L |
| Net Interest Income | -₹2,384.60L | -₹835.69L | ₹2,378.13L | -₹3.93L | ₹0.00L | ₹0.00L |
| Total Unusual Items | -₹1,212.58L | ₹108.76L | ₹376.24L | ₹315.23L | ₹0.00L | ₹0.00L |
| Basic Average Shares | ₹3,245.22L | ₹3,245.22L | ₹3,245.22L | ₹2,846.96L | ₹0.00L | ₹0.00L |
| Diluted Average Shares | ₹3,245.22L | ₹3,245.22L | ₹3,245.22L | ₹2,846.96L | ₹0.00L | ₹0.00L |
| Total Other Finance Cost | ₹254.53L | ₹50.00L | ₹50.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Other Operating Expenses | ₹2,376.74L | ₹3,119.01L | ₹3,568.17L | ₹2,910.21L | ₹0.00L | ₹0.00L |
| Reconciled Depreciation | ₹1,020.79L | ₹1,239.48L | ₹1,251.05L | ₹1,177.08L | ₹0.00L | ₹0.00L |
| Reconciled Cost Of Revenue | ₹5,138.79L | ₹10,995.96L | ₹13,578.59L | ₹17,673.65L | ₹0.00L | ₹0.00L |
| Rent Expense Supplemental | ₹32.83L | ₹0.00L | ₹25.08L | ₹0.00L | ₹0.00L | ₹0.00L |
| Tax Effect Of Unusual Items | -₹485.03L | ₹0.09L | ₹112.87L | ₹0.00L | ₹0.00L | ₹0.00L |
| Interest Income Non Operating | ₹1,028.73L | ₹68.21L | ₹2,547.59L | ₹759.54L | ₹0.00L | ₹0.00L |
| Interest Expense Non Operating | ₹3,158.80L | ₹853.90L | ₹119.46L | ₹763.47L | ₹0.00L | ₹0.00L |
| Net Income Common Stockholders | ₹1,55,320.43L | -₹34,250.94L | -₹38,721.39L | -₹22,258.35L | ₹0.00L | ₹0.00L |
| Net Income Continuous Operations | ₹1,55,320.43L | -₹34,250.94L | -₹38,721.39L | -₹22,258.35L | ₹0.00L | ₹0.00L |
| Diluted NIAvailto Com Stockholders | ₹1,55,320.43L | -₹34,250.94L | -₹38,721.39L | -₹22,258.35L | ₹0.00L | ₹0.00L |
| General And Administrative Expense | ₹7,183.22L | ₹9,399.17L | ₹15,448.27L | ₹13,343.92L | ₹0.00L | ₹0.00L |
| Selling General And Administration | ₹7,183.22L | ₹9,399.17L | ₹15,448.27L | ₹13,343.92L | ₹0.00L | ₹0.00L |
| Otherunder Preferred Stock Dividend | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Unusual Items Excluding Goodwill | -₹1,212.58L | ₹108.76L | ₹376.24L | ₹315.23L | ₹0.00L | ₹0.00L |
| Net Non Operating Interest Income Expense | -₹2,384.60L | -₹835.69L | ₹2,378.13L | -₹3.93L | ₹0.00L | ₹0.00L |
| Net Income Including Noncontrolling Interests | ₹1,55,320.43L | -₹34,250.94L | -₹38,721.39L | -₹22,258.35L | ₹0.00L | ₹0.00L |
| Net Income From Continuing And Discontinued Operation | ₹1,55,320.43L | -₹34,250.94L | -₹38,721.39L | -₹22,258.35L | ₹0.00L | ₹0.00L |
| Net Income From Continuing Operation Net Minority Interest | ₹1,55,320.43L | -₹34,250.94L | -₹38,721.39L | -₹22,258.35L | ₹0.00L | ₹0.00L |
Company Performance (FY14–FY26)
Directors
| Appointment | Director name | DIN | Designation | |
|---|---|---|---|---|
| 01/03/2006 | Dilip Shantilal Shanghvi | 00005588 | Director | View other directorships |
| 04/06/2007 | Rajamannar Thennati | 01415412 | Director | View other directorships |
| 01/06/2020 | Robert Jay Spiegel | 08739625 | Director | View other directorships |
| 25/05/2021 | Anil Kumar | *****1479C | CEO | |
| 22/09/2023 | Kajal Kiran Damania | *****0075J | Company Secretary | |
| 06/06/2024 | Anup Madanmohan Rathi | *****1544G | CFO | |
| 15/07/2024 | Vidhi Dilip Shanghvi | 06497350 | Director | View other directorships |
| 19/05/2025 | Venkateswarlu Jasti | 00278028 | Director | View other directorships |
| 19/05/2025 | Rekha Gopal Warriar | 08152356 | Director | View other directorships |
Business Network
Directors 9
- Rekha Gopal WarriarDirector
- Venkateswarlu JastiDirector
- Vidhi Dilip ShanghviDirector
- Robert Jay SpiegelDirector
- Rajamannar ThennatiDirector
- Dilip Shantilal ShanghviDirector
- Anup Madanmohan RathiCFO
- Kajal Kiran DamaniaCompany Secretary
- Anil KumarCEO
Latest Documents
| Date | Title | Size |
|---|---|---|
| 10/10/2024 | Form MGT-7-10102024_signed | - |
| 09/10/2024 | Form MGT-7-09102024 | - |
| 20/09/2024 | Form AOC-4(XBRL)-10092024 | - |
| 10/09/2024 | Form AOC-4(XBRL)-10092024 | - |
| 10/09/2024 | Form AOC-4(XBRL)-10092024_signed | - |
Charges
| SRN | Date | Amount | Holder |
|---|---|---|---|
| AC0381367 | 17/03/2022 | ₹1,45,00,00,000.00 | Icici Bank Limited |
| AB5694896 | 18/02/2021 | ₹4,00,00,00,000.00 | Kotak Mahindra Bank |
Similar Companies
| Company | CIN | Address |
|---|---|---|
| Cfc Laboratories Limited | L73100DL1985PLC022747 | 458-466, Gali No.8, Shambunath Compound Friends Colony, Industrial Area, New Delhi, Delhi, India, 110065 |
| Gsm Institute Of Medical And Technologic Al Sciences Limited | L73100AP2004PLC044380 | H.no.12-234-1, Near Tagore Vidya Niketan, Shareen Nagar, Kurnool-2 Shareen Nagar, Kurnool-2 Ap 000000 In |
| Hexagon Engineers Limited | L73100KA1994PLC015543 | No.93/2 Between 11th And 12th Cross, Malleswaram, Margosa Road, Bangalore, Bangalore, Karnataka, India, 560003 |
| Infollion Research Services Limited | L73100HR2009PLC126450 | 5th Floor, Tower C, Unitech Cyber Park, Sector 39, Gurugram, Gurgaon, Gurgaon, Sadar Bazar, Haryana, India, 122001 |
| Regal Enterprises Ltd | L73100DL1989PLC269075 | Shop No G-2 Plot No 5, Kohli Plaza Block-cu Market, Pitampura, Maurya Enclave, North West Delhi, Delhi, Delhi, India, 110034 |
Address
Frequently Asked Questions
The current board member of Sun Pharma Advanced Research Company Limited are:
- Rajamannar Thennati
- Robert Jay Spiegel
- Dilip Shantilal Shanghvi
- Anil Kumar
- Venkateswarlu Jasti
- Rekha Gopal Warriar
- Vidhi Dilip Shanghvi
- Anup Madanmohan Rathi
- Kajal Kiran Damania